{"id":"NCT01854918","sponsor":"Amgen","briefTitle":"Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia","officialTitle":"A Multicenter, Controlled, Open-label Extension (OLE) Study to Assess the Long-term Safety and Efficacy of AMG 145","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04-23","primaryCompletion":"2018-05-31","completion":"2018-05-31","firstPosted":"2013-05-16","resultsPosted":"2019-06-11","lastUpdate":"2019-06-11"},"enrollment":3681,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hyperlipidemia and Mixed Dyslipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Standard of Care","otherNames":[]}],"arms":[{"label":"Standard of Care","type":"ACTIVE_COMPARATOR"},{"label":"Evolocumab + Standard of Care","type":"EXPERIMENTAL"}],"summary":"This study will contribute to the evaluation of long-term safety, tolerability and efficacy of evolocumab (AMG 145) in adults with hyperlipidemia and adults with mixed dyslipidemia.","primaryOutcome":{"measure":"Number of Participants With Adverse Events","timeFrame":"48 weeks in the SOC-controlled period and up to 2 years in the All-IP period","effectByArm":[{"arm":"Year 1: Standard of Care","deltaMin":796,"sd":null},{"arm":"Year 1: Evolocumab + Standard of Care","deltaMin":1655,"sd":null},{"arm":"Years 2-3: SOC / Evolocumab + SOC","deltaMin":929,"sd":null},{"arm":"Years 2-3: Evolocumab + SOC / Evolocumab + SOC","deltaMin":1789,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":4},"locations":{"siteCount":363,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","France","Germany","Hong Kong","Hungary","Italy","Japan","Netherlands","New Zealand","Norway","Poland","Russia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","United Kingdom"]},"refs":{"pmids":["29353350","28844508","29066265","33078867","25773607"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":104,"n":1227},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Hypertension","Arthralgia","Back pain"]}}